HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jia Cao Selected Research

Scavenger Receptors (Scavenger Receptor)

7/2021Hepatic paraoxonase 1 ameliorates dysfunctional high-density lipoprotein and atherosclerosis in scavenger receptor class B type I deficient mice.
1/2020Methionine sulfoxide reductase A attenuates atherosclerosis via repairing dysfunctional HDL in scavenger receptor class B type I deficient mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jia Cao Research Topics

Disease

39Neoplasms (Cancer)
05/2024 - 11/2007
17Carcinogenesis
02/2023 - 02/2008
13Colorectal Neoplasms (Colorectal Cancer)
12/2023 - 11/2007
11Inflammation (Inflammations)
02/2024 - 07/2013
10Lung Neoplasms (Lung Cancer)
02/2023 - 06/2010
9Neoplasm Metastasis (Metastasis)
05/2024 - 01/2016
8Breast Neoplasms (Breast Cancer)
12/2022 - 09/2010
8Pancreatic Neoplasms (Pancreatic Cancer)
01/2020 - 03/2010
6Atherosclerosis
07/2021 - 01/2013
6Hepatocellular Carcinoma (Hepatoma)
01/2020 - 12/2008
5Stomach Neoplasms (Stomach Cancer)
05/2024 - 04/2011
5Osteoporosis
12/2021 - 01/2018
5Wounds and Injuries (Trauma)
10/2020 - 01/2018
4Infertility (Sterility)
08/2023 - 01/2016
4Male Infertility (Male Sterility)
03/2020 - 10/2016
4Chromosome Aberrations (Chromosome Abnormalities)
08/2013 - 07/2002
3Fibrosis (Cirrhosis)
08/2022 - 01/2020
3Body Weight (Weight, Body)
08/2022 - 01/2007
3Hypertension (High Blood Pressure)
01/2022 - 01/2015
3Parkinson Disease (Parkinson's Disease)
04/2018 - 06/2013
3Radiation Injuries (Radiation Sickness)
09/2014 - 07/2013
3Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
04/2011 - 07/2002
3Leukemia
03/2003 - 03/2002
2Obesity
12/2023 - 01/2017
2Traumatic Brain Injuries (Traumatic Brain Injury)
11/2023 - 10/2022
2Liver Diseases (Liver Disease)
01/2023 - 12/2021
2Infections
01/2023 - 08/2022
2Hemorrhage
09/2022 - 04/2015
2Lung Injury
08/2022 - 08/2008
2Bone Resorption
01/2022 - 01/2018
2Metabolic Diseases (Metabolic Disease)
12/2021 - 01/2018
2Mitochondrial Diseases (Mitochondrial Disease)
11/2021 - 01/2019
2Edema (Dropsy)
11/2020 - 12/2014
2Burns
10/2020 - 01/2020
2Ovarian Neoplasms (Ovarian Cancer)
02/2020 - 01/2019
2Osteosarcoma (Osteogenic Sarcoma)
01/2020 - 12/2011
2Cicatrix (Scar)
01/2020 - 01/2018
2Carcinoma (Carcinomatosis)
01/2020 - 06/2010

Drug/Important Bio-Agent (IBA)

24Proteins (Proteins, Gene)FDA Link
02/2024 - 03/2010
16Biomarkers (Surrogate Marker)IBA
02/2023 - 08/2013
8CateninsIBA
02/2023 - 01/2017
7Small Interfering RNA (siRNA)IBA
08/2023 - 09/2010
7Messenger RNA (mRNA)IBA
02/2023 - 12/2012
6CholesterolIBA
12/2021 - 10/2015
6DNA (Deoxyribonucleic Acid)IBA
01/2021 - 07/2002
5Long Noncoding RNAIBA
05/2024 - 01/2020
5MethylcholanthreneIBA
01/2021 - 08/2009
5MicroRNAs (MicroRNA)IBA
06/2020 - 09/2017
4Circular RNAIBA
02/2024 - 01/2020
4Reactive Oxygen Species (Oxygen Radicals)IBA
11/2022 - 12/2018
4Estrogens (Estrogen)FDA Link
08/2022 - 12/2008
4Apolipoproteins E (ApoE)IBA
12/2021 - 10/2015
4RotenoneIBA
11/2021 - 06/2013
4Aryldialkylphosphatase (Paraoxonase)IBA
07/2021 - 06/2012
4HDL LipoproteinsIBA
07/2021 - 06/2012
4CytokinesIBA
06/2021 - 08/2008
4EnzymesIBA
01/2013 - 01/2007
4CarcinogensIBA
07/2012 - 02/2008
4Diethylnitrosamine (N-Nitrosodiethylamine)IBA
02/2011 - 08/2009
4Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA
03/2003 - 03/2002
3HomoharringtonineIBA
08/2023 - 04/2018
3Phosphotransferases (Kinase)IBA
11/2022 - 07/2008
3ApolipoproteinsIBA
12/2021 - 10/2015
3Transcription Factors (Transcription Factor)IBA
10/2021 - 11/2017
3Eosine Yellowish-(YS) (Eosin)IBA
10/2021 - 01/2020
3Hematoxylin (Haematoxylon)IBA
10/2021 - 01/2020
3AlkaloidsIBA
01/2021 - 10/2003
3Antineoplastic Agents (Antineoplastics)IBA
01/2021 - 01/2014
3Glucose (Dextrose)FDA LinkGeneric
01/2020 - 09/2012
31-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2018 - 01/2017
3Peptides (Polypeptides)IBA
08/2018 - 12/2008
3SmokeIBA
12/2014 - 08/2008
3CaspasesIBA
09/2014 - 03/2013
3Cytochrome P-450 CYP2E1 (CYP2E1)IBA
07/2012 - 11/2007
2CurcuminIBA
11/2023 - 10/2022
2Metformin (Glucophage)FDA LinkGeneric
08/2023 - 08/2022
2Air Pollutants (Pollutants, Air)IBA
08/2023 - 01/2020
2Therapeutic UsesIBA
08/2023 - 01/2020
2LuciferasesIBA
02/2023 - 11/2017
2RNA (Ribonucleic Acid)IBA
01/2023 - 03/2013
2LipidsIBA
11/2022 - 12/2021
2InflammasomesIBA
11/2022 - 07/2013
2Cadherins (E-Cadherin)IBA
08/2022 - 02/2011
2LipopolysaccharidesIBA
08/2022 - 01/2017
2Carrier Proteins (Binding Protein)IBA
10/2021 - 06/2018
2Scavenger Receptors (Scavenger Receptor)IBA
07/2021 - 01/2020
2SteroidsIBA
06/2021 - 04/2015
2Hormones (Hormone)IBA
06/2021 - 01/2020
2SilverIBA
10/2020 - 01/2020
2Indicators and Reagents (Reagents)IBA
02/2020 - 01/2019
2Cisplatin (Platino)FDA LinkGeneric
01/2020 - 05/2018

Therapy/Procedure

10Therapeutics
01/2023 - 12/2012
4Ovariectomy (Oophorectomy)
01/2022 - 11/2019
4Lasers (Laser)
01/2020 - 03/2005
3Intravenous Injections
01/2020 - 11/2019
3Quantum Dots (Quantum Dot)
08/2018 - 06/2016
3Radiotherapy
03/2013 - 07/2002
2Operative Time
01/2023 - 09/2022
2Aftercare (After-Treatment)
01/2020 - 12/2012
2Optical Fibers
01/2020 - 01/2017